BREAKING: Second interim analysis of clinical trial data showed a 91.4% efficacy for the #SputnikV vaccine on day 28 after the first dose; vaccine efficacy is over 95% 42 days after the first dose. Read More: https://t.co/qfCZ9FG8WH — Sputnik V (@sputnikvaccine) November 24, 2020
BREAKING: Second interim analysis of clinical trial data showed a 91.4% efficacy for the #SputnikV vaccine on day 28 after the first dose; vaccine efficacy is over 95% 42 days after the first dose. Read More: https://t.co/qfCZ9FG8WH